Skip to content

Facilitating Communication Study

Evaluating Effectiveness of a Communication Facilitator to Reduce Distress and Improve Goal Concordant Care for Critically Ill Patients and Their Families: A Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03721952
Acronym
FCS2
Enrollment
977
Registered
2018-10-26
Start date
2019-04-17
Completion date
2024-06-30
Last updated
2025-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injuries, Cerebrovascular Disorders, Chronic Disease, Health Care Quality, Access, and Evaluation, Heart Failure, Congestive, Intensive Care Units, Kidney Failure, Chronic, Liver Cirrhosis, Lung Diseases, Lung Neoplasm, Multiple Organ Failure, Neoplasm Metastasis, Palliative Care, Health Services, Palliative Care, Patient Care, Pulmonary Disease, Chronic Obstructive

Brief summary

This study is a randomized clinical trial of an intervention to improve outcomes for patients and their family by using ICU nurse facilitators to support, model, and teach communication strategies that enable patients and their families to secure care in line with patients' goals of care over an illness trajectory, beginning in the ICU and continuing to care in the community.

Detailed description

The impact of critical illness is increasing due to an aging population as well as advances in effectiveness and availability of critical care. Critically ill patients and their families suffer a high burden of symptoms of depression, anxiety, and post-traumatic stress due, in part, to fragmented medical care that is often poorly aligned with their goals. Fragmented care includes numerous transitions for patients and families across clinicians and across settings, starting in the intensive care unit (ICU) and extending to acute care, skilled nursing facilities, or home. As illness progresses, patients and families struggle to navigate the spectrum of goals of care, to match their values and goals with treatments, to communicate their goals to their clinicians, and to make difficult medical decisions without letting unmet emotional needs interfere. Poor communication exacerbated by these transitions compounds an already stressful experience, causing distress to patients and their families. Taken together, these issues lead to ineffective communication during and after the ICU which can often result in high intensity default care that may be unwanted. Using a randomized trial, this project aims to evaluate an innovative model of care in which ICU nurse facilitators support, model, and teach communication strategies that enable patients and families to secure care in line with their goals over an illness trajectory, beginning in the ICU and continuing into the community. Facilitators use communication skills, attachment theory, and mediation to improve: 1) patients' and families' self-efficacy to communicate with clinicians within and across settings; 2) patients' and families' outcome expectation that communication with clinicians can improve their care; and 3) patients' and families' behavioral capability through skill building to resolve barriers to effective communication and mediate conflict. Facilitators work with seriously ill patients and their families beginning with a critical care unit stay and following them over the course of three months. The intervention's effectiveness will be measured with patient- and family-centered outcomes at 1-, 3-, and 6-months post-randomization. The primary outcome is family members' burden of symptoms of depression over the 6 months. The investigators also evaluate whether the intervention improves the value of healthcare by reducing healthcare costs while improving patient and family outcomes. Finally, investigators use qualitative methods to explore implementation factors (intervention, settings, individuals, processes) associated with improved implementation outcomes (acceptability, fidelity, penetration) to inform dissemination of this type of intervention to support patients and their families. This study aims to address key knowledge gaps while evaluating a methodologically rigorous intervention to improve outcomes for patients with serious illness and their families across the trajectory of care and the spectrum of goals of care.

Interventions

Facilitators interact in person or by telephone with patients, family, and clinicians both during and following the patient's ICU stay for 3 months. In-person contacts include visits to patients' homes and/or care facilities; phone contacts include calls to patients, families and clinicians. Patients and families have access to facilitators through phone and email 5 days per week. Facilitators may attend clinic visits with patients. In addition to checking directly with patients/families during regular contacts, facilitators also access the electronic health record to ensure they have accurate information about appointments and treatment plans and to document key points for the clinical team. Facilitators encourage referral to inpatient or outpatient palliative care services when needs are identified.

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* PATIENTS. Eligible patients 18 years of age or older, English-speaking, with a chronic life-limiting illness suggesting a median survival of approximately 2 years or a severe acute illness with a risk of hospital mortality of at least 15%. Chronic life-limiting illnesses include: cancer with a poor prognosis (e.g. metastatic cancer); chronic pulmonary disease (e.g. COPD, restrictive lung disease); coronary artery disease (CAD); congestive heart failure (CHF); peripheral vascular disease (PVD); severe liver disease (e.g. cirrhosis); diabetes with end-organ damage; renal failure (e.g. ESRD); and dementia. Acute illness criteria include a SOFA, APACHE or trauma severity score predicting a 15% or greater risk of hospital mortality. Acute illnesses and conditions also include: age \>=80 years; acute respiratory distress syndrome (ARDS) with P/F ratio \<=300; subarachnoid hemorrhage (SAH) Fisher grade 3/4 with Glasgow coma score (GCS) \<=12; spontaneous hemorrhage (ICH, IPH, EDH, SDH) with GCS \<=12; stroke or cardiovascular accident (CVA) with GCS \<=12; decompressive/crash craniotomy (bone flap) with GCS \<=12; traumatic brain injury (TBI) or diffuse axonal injury (DAI) based on MRI \ day 10; or anoxic brain injury due to cardiac arrest \>48 hours. All potential participants screened for facility with English and absence of significant cognitive impairment (prior to their current hospitalization) that would limit their ability to complete survey instruments. * FAMILY. Eligible family subjects18 years of age or older, English-speaking, and identified as someone involved in patient's medical care or decision-making. Eligible family may include any of the following: legal guardians, durable power of attorney for healthcare, spouses, adult children, parents, siblings, domestic partners, other relatives, and friends. * CLINICIAN AND ADMINISTRATOR INTERVIEW SUBJECTS. Eligible clinicians and administrators 18 years of age or older, English-speaking, employed at a participating hospital and have a familiarity with the study and the intervention.

Exclusion criteria

* PATIENTS. We will exclude patients with an anticipated ICU stay of less than 2 days, as assessed by the critical care attending physician or his/her designee. We will exclude patients who have been in the ICU for more than 14 days. * PATIENTS AND FAMILY. Reasons for exclusion for patient and family member subject groups include: legal or risk management concerns (as determined by the attending physician or via hospital record designation); psychological illness or morbidity; and physical or mental limitations preventing ability to complete questionnaires. * CLINICIAN AND ADMINISTRATOR INTERVIEW SUBJECTS. n/a

Design outcomes

Primary

MeasureTime frameDescription
Depression Symptoms, Family (HADS-D)1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline valueFamily member symptoms of depression and anxiety assessed with the Hospital Anxiety and Depression Scale (HADS). The HADS is a reliable and valid 14-item, 2-domain (anxiety and depression) tool used to assess symptoms of psychological distress. Seven items evaluate anxiety and seven evaluate depression. Each item is scored on a 4-point scale (ranging from 0-3. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the sum of 7 items measuring depression, weighted for the number of items with valid responses. The sum could range from 0 to 21, with higher values indicating greater depression (i.e., worse outcome),

Secondary

MeasureTime frameDescription
Impact of Event, Family Assessment (IES-6)1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcomeThe Impact of Event Scale-6 (IES-6), derived from the IES-R, uses six self-report items to assess subjective distress caused by a traumatic event. Items are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely). For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the sum of 6 items measuring the traumatic impact of events, weighted for the number of items with valid responses. The sum could range from 0 to 24, with higher values indicating greater traumatic impact (i.e., worse outcome)
Healthcare Utilization: Hospital Free Days, 183 Days - Patient183 days after randomizationNumber of full days on which the patient was alive and not in the hospital between the randomization date and 182 days after the randomization date. Values could range from 0 to 183, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.
Healthcare Utilization: ICU Free Days, 30 Days - Patient30 days after randomizationNumber of full days on which the patient was alive and not in an ICU between the randomization date and 29 days after the randomization date. Values could range from 0 to 30, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.
Healthcare Utilization: ICU Free Days, 91 Days - Patient91 days after randomizationNumber of full days on which the patient was alive and not in an ICU between the randomization date and 90 days after the randomization date. Values could range from 0 to 91, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.
Healthcare Utilization: ICU Free Days, 183 Days - Patient183 days after randomizationNumber of full days on which the patient was alive and not in an ICU between the randomization date and 182 days after the randomization date. Values could range from 0 to 183, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.
Healthcare Costs, Discharge - PatientRandomization to discharge from index hospitalization, up to 183 daysTotal hospitalization costs from date of randomization to index hospitalization discharge. Costs ranged from $1,631.73 to $1,299,781.53, with higher value indicating a worse outcome; missing if the patient was randomized after discharge from the index hospitalization.
Healthcare Costs, 30 Days - PatientRandomization to 30 days after randomizationTotal hospitalization costs for the 30-day period beginning with the date of randomization, adjusted to their value in December 2023 based on the Consumer Price Index for Medical Care. Values ranged from $1,631.73 to $585,386.34, with higher values indicating worse outcomes; missing if the patient was randomized after index hospitalization discharge.
Anxiety Symptoms, Family (HADS-A)1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline valueFamily member symptoms of depression and anxiety assessed with the Hospital Anxiety and Depression Scale (HADS). The HADS is a reliable and valid 14-item, 2-domain (anxiety and depression) tool used to assess symptoms of psychological distress. Seven items evaluate anxiety and seven evaluate depression. Each item is scored on a 4-point scale (ranging from 0-3. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the sum of 7 items measuring anxiety, weighted for the number of items with valid responses. The sum could range from 0 to 21, with higher values indicating greater anxiety (i.e., worse outcome)
Quality of Family Experience - Relationship With Healthcare Providers (QUAL-E Fam)1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline valueMeasure of family experience of patients with serious illness. The QUAL-E (Fam) is a validated 17-item companion instrument to the patient QUAL-E measure of quality of life at the end of life, with four subscales and two general items. This study is using 11 items from three subscales: Relationship with Health Care Provider, Completion, and Preparation subscales. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the mean of the valid responses to QUAL-E (Fam) items #5, 6, 7, and 8. The mean could range from 1 to 5, with higher values indicating higher quality of relationship (i.e., better outcome).
Quality of Family Experience - Sense of Completion (QUAL-E Fam)1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline valueMeasure of family experience of patients with serious illness. The QUAL-E (Fam) is a validated 17-item companion instrument to the patient QUAL-E measure of quality of life at the end of life, with four subscales and two general items. This study is using 11 items from three subscales: Relationship with Health Care Provider, Completion, and Preparation subscales. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the mean of the valid responses to QUAL-E (Fam) items #9, 10, and 11. The mean could range from 1 to 5, with higher values indicating higher sense of completion (i.e., better outcome).
Quality of Family Experience - Preparation Issues (QUAL-E Fam)1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline valueMeasure of family experience of patients with serious illness. The QUAL-E (Fam) is a validated 17-item companion instrument to the patient QUAL-E measure of quality of life at the end of life, with four subscales and two general items. This study is using 11 items from three subscales: Relationship with Health Care Provider, Completion, and Preparation subscales. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the sum of valid responses to QUAL-E (Fam) items #12, 13, 14, and 15, weighted for the number of items with valid responses. The sum could range from 4 to 20, with higher values indicating greater preparation (i.e., better outcome).
Goal-Concordant Care, Family Assessment1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline valueConcordance between the care patients want and the care they receive is measured with two questions from the SUPPORT study. The first defines preference (care focused on extending life even with more pain and discomfort vs. care focused on relieving pain and discomfort even with not living as long.) The second assesses perception of current treatment using the same options. The outcome is a dichotomous variable of whether preference matches care received. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was coded 1 if the respondent's perception of the focus of care the patient received (comfort vs. life extension) matched their perception of the patient's preferred focus of care; and 0 if the perceived focus of care received did not match the perceived patient's care preference. If the response to either item was don't know, the outcome was coded 0. The higher value indicated goal-concordant care (the better outcome).
Healthcare Utilization: Hospital Readmission - Patientwithin 30 days after discharge from the index hospitalizationDocumentation in the patient's electronic health record of hospital readmission within 30 days after discharge from the index hospitalization: 0=no readmission, 1=one or more readmissions; missing if index hospitalization still ongoing at the end of the 183-day follow-up period, patient death during index hospitalization, or randomization occurred after index hospitalization discharge. Valid outcomes could be either 0 or 1, with higher value indicating a worse outcome.
Healthcare Utilization: Hospital Free Days, 30 Days - Patient30 days after randomizationNumber of full days on which the patient was alive and not in the hospital between the randomization date and 29 days after the randomization date. Values could range from 0 to 30, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.
Healthcare Utilization: Hospital Free Days, 91 Days - Patient91 days after randomizationNumber of full days on which the patient was alive and not in the hospital between the randomization date and 90 days after the randomization date. Values could range from 0 to 91, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.

Other

MeasureTime frameDescription
Perceived Competence Scale (PCS), 6 Months - FamilyAssessed on 6-month questionnairesThe Perceived Competence Scale (PCS) is a 4-item questionnaire assessing participants' feelings of competence. Items can be worded differently for different target behaviors. Responses range from Not at all true (1) to Very True (7); higher score on the latent variable would indicate greater competence. We will evaluate this mediator cross-sectionally.
Measure of Acceptability of Intervention - Family in the Intervention GroupAssessed on 3-month questionnairesThe Acceptability of Intervention Measure (AIM) is a 4 item measure with proven reliability, validity and responsiveness to change. It is designed to assess participants' perception of the intervention in which they participated as agreeable (meets my approval), palatable (appealing to me) or satisfactory (like it, welcome it). Response options include completely disagree, disagree, neither agree nor disagree, agree and completely agree. These items were asked of the intervention participants at the conclusion of the 3-month intervention phase.
Key Implementation Factors6-months after randomizationQualitative interviews after individual participation. Interviews will be guided by the Consolidated Framework for Implementation Research (CFIR) to explore the factors associated with implementation, including aspects of the intervention, inner and outer settings, individuals, and processes of care. Individual constructs within these domains were chosen to fit this specific intervention and context.
Key Implementation Outcomes6-months after randomizationQualitative interviews after individual participation. Interviews will also explore three key implementation outcomes (acceptability, fidelity, penetration) that will guide future dissemination of the intervention.
Perceived Competence Scale (PCS), 3 Months - FamilyAssessed on 3-month questionnairesThe Perceived Competence Scale (PCS) is a 4-item questionnaire assessing participants' feelings of competence. Items can be worded differently for different target behaviors. Responses range from Not at all true (1) to Very True (7); higher score on the latent variable would indicate greater competence. We will evaluate this mediator cross-sectionally.
Perceived Competence Scale (PCS), 1 Month - FamilyAssessed on 1-month questionnairesThe Perceived Competence Scale (PCS) is a 4-item questionnaire assessing participants' feelings of competence. Items can be worded differently for different target behaviors. Responses range from Not at all true (1) to Very True (7); higher score on the latent variable would indicate greater competence. We will evaluate this mediator cross-sectionally.

Countries

United States

Participant flow

Recruitment details

Patients and family were screened and recruited from April 2019 to March 2023. Potential subjects received introductory calls from the research coordinator to assess interest and eligibility. Enrollees completed baseline surveys and were randomized. Patients and family were approached for interviews between March 2020 and December 2022. Clinicians and administrators were recruited between January 2021 and January 2023.

Pre-assignment details

2823 patients and family were assessed for eligibility. 1806 were excluded; main reasons included: family or legal next of kin unavailable, and patient status improved/transferred from ICU. 568 declined participation; main reason given was the family member feeling overwhelmed. 505 family subjects were enrolled, representing 449 enrolled patients.

Participants by arm

ArmCount
Usual Care/CONTROL: Patient
Received Usual Care and/or Attention Control; patient subjects did not complete surveys
224
Facilitator-Based INTERVENTION: Patient
Received 3-Month Communication Facilitator Intervention; patient subjects did not complete surveys
225
Usual Care/CONTROL: Family
Received Usual Care and/or Attention Control; family member subjects completed follow-up outcome surveys at 1-3-6 months after randomization
241
Facilitator-Based INTERVENTION: Family
Received 3-Month Communication Facilitator Intervention; family member subjects completed follow-up outcome surveys at 1-3-6 months after randomization
264
Clinician & Administrator Interviewees
Subjects participated in qualitative interviews designed to evaluate the intervention
23
Total977

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004
Overall StudyLost to Follow-up00200
Overall StudyProtocol Violation01000
Overall StudyWithdrawal by Subject1040280

Baseline characteristics

CharacteristicUsual Care/CONTROL: PatientTotalClinician & Administrator IntervieweesFacilitator-Based INTERVENTION: FamilyUsual Care/CONTROL: FamilyFacilitator-Based INTERVENTION: Patient
Age, Continuous58 years55 years39.5 years55 years53 years57 years
Age, Customized
<= 18 years
1 Participants1 Participants0 Participants0 Participants0 Participants0 Participants
Age, Customized
>= 65 years
77 Participants274 Participants1 Participants63 Participants54 Participants79 Participants
Age, Customized
Between 18 and 65 years
146 Participants683 Participants15 Participants197 Participants179 Participants146 Participants
Age, Customized
Unknown or Not Reported
0 Participants19 Participants7 Participants4 Participants8 Participants0 Participants
Anxiety Symptoms, Family (HADS-A)10.4 scores on a scale
STANDARD_DEVIATION 4.7
10.5 scores on a scale
STANDARD_DEVIATION 4.7
10.4 scores on a scale
STANDARD_DEVIATION 4.8
APACHE II Score, Patients25 APACHE II Severity of Disease Score25 APACHE II Severity of Disease Score24 APACHE II Severity of Disease Score
Depression Symptoms, Family (HADS-D)7.2 scores on a scale
STANDARD_DEVIATION 4.4
7.2 scores on a scale
STANDARD_DEVIATION 4.2
7.2 scores on a scale
STANDARD_DEVIATION 4.6
Diagnoses, Patients
Acute-ARDS (acute respiratory distress syndrome)
45 Participants101 Participants0 Participants0 Participants0 Participants56 Participants
Diagnoses, Patients
Acute-ICU Admission with COVID-19
28 Participants56 Participants0 Participants0 Participants0 Participants28 Participants
Diagnoses, Patients
Acute-New spinal cord injury (SCI) with Quadriplegia
3 Participants6 Participants0 Participants0 Participants0 Participants3 Participants
Diagnoses, Patients
Acute-On ECMO/ECLS (extracorporeal life support)
5 Participants5 Participants0 Participants0 Participants0 Participants0 Participants
Diagnoses, Patients
Acute-Respiratory Failure
177 Participants351 Participants0 Participants0 Participants0 Participants174 Participants
Diagnoses, Patients
Acute-TBI (traumatic brain injury)
27 Participants67 Participants0 Participants0 Participants0 Participants40 Participants
Diagnoses, Patients
Acute-Vascular/non-TBI (non-traumatic brain injury)
73 Participants138 Participants0 Participants0 Participants0 Participants65 Participants
Diagnoses, Patients
Chronic-CAD (coronary artery disease)
38 Participants72 Participants0 Participants0 Participants0 Participants34 Participants
Diagnoses, Patients
Chronic-Cancer
25 Participants45 Participants0 Participants0 Participants0 Participants20 Participants
Diagnoses, Patients
Chronic-CHF (congestive heart failure)
55 Participants108 Participants0 Participants0 Participants0 Participants53 Participants
Diagnoses, Patients
Chronic-COPD (chronic obstructive pulmonary disease)
33 Participants59 Participants0 Participants0 Participants0 Participants26 Participants
Diagnoses, Patients
Chronic-Dementia
8 Participants23 Participants0 Participants0 Participants0 Participants15 Participants
Diagnoses, Patients
Chronic-Diabetes
17 Participants39 Participants0 Participants0 Participants0 Participants22 Participants
Diagnoses, Patients
Chronic-Had 3+ Diagnoses
69 Participants131 Participants0 Participants0 Participants0 Participants62 Participants
Diagnoses, Patients
Chronic-Liver Disease
25 Participants44 Participants0 Participants0 Participants0 Participants19 Participants
Diagnoses, Patients
Chronic-PVD (peripheral vascular disease)
26 Participants38 Participants0 Participants0 Participants0 Participants12 Participants
Diagnoses, Patients
Chronic-Renal Failure
39 Participants71 Participants0 Participants0 Participants0 Participants32 Participants
Education Level, Family
4-year college degree
107 Participants52 Participants55 Participants
Education Level, Family
8th grade or less
1 Participants0 Participants1 Participants
Education Level, Family
Graduate degree
82 Participants45 Participants37 Participants
Education Level, Family
High school diploma/GED
58 Participants29 Participants29 Participants
Education Level, Family
Some graduate school
20 Participants11 Participants9 Participants
Education Level, Family
Some high school
13 Participants6 Participants7 Participants
Education Level, Family
Trade school or some college
224 Participants121 Participants103 Participants
Employment Status, Family
Disabled
32 Participants12 Participants20 Participants
Employment Status, Family
Full-time
238 Participants133 Participants105 Participants
Employment Status, Family
Other
32 Participants17 Participants15 Participants
Employment Status, Family
Part-time
50 Participants23 Participants27 Participants
Employment Status, Family
Retired
106 Participants56 Participants50 Participants
Employment Status, Family
Unemployed
38 Participants18 Participants20 Participants
Employment Status, Family
Unknown, not reported
9 Participants5 Participants4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
13 Participants75 Participants0 Participants23 Participants21 Participants18 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
199 Participants861 Participants23 Participants234 Participants215 Participants190 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
12 Participants41 Participants0 Participants7 Participants5 Participants17 Participants
Financial Situation, Family
Difficulty paying bills no matter what
35 Participants14 Participants21 Participants
Financial Situation, Family
Enough money as a result of cutting back
81 Participants44 Participants37 Participants
Financial Situation, Family
Enough money for special things
226 Participants119 Participants107 Participants
Financial Situation, Family
Enough money to pay bills but little for extra things
152 Participants81 Participants71 Participants
Financial Situation, Family
Unknown, not reported
11 Participants6 Participants5 Participants
Goal-Concordant Care, Family Assessment259 Participants136 Participants123 Participants
Health Status, Family
Excellent
57 Participants26 Participants31 Participants
Health Status, Family
Fair
62 Participants35 Participants27 Participants
Health Status, Family
Good
174 Participants91 Participants83 Participants
Health Status, Family
Poor
10 Participants4 Participants6 Participants
Health Status, Family
Unknown, not reported
2 Participants1 Participants1 Participants
Health Status, Family
Very Good
200 Participants107 Participants93 Participants
Hospital Site
Community Hospital
12 Participants54 Participants0 Participants15 Participants13 Participants14 Participants
Hospital Site
County Hospital
167 Participants719 Participants8 Participants198 Participants181 Participants165 Participants
Hospital Site
More than One Hospital Location
0 Participants4 Participants4 Participants0 Participants0 Participants0 Participants
Hospital Site
University Hospital
45 Participants200 Participants11 Participants51 Participants47 Participants46 Participants
Perceived Competence, FAMILY
I am able to get the care for my family member that he/she wants.
6 units on a scale6 units on a scale6 units on a scale
Perceived Competence, FAMILY
I am capable of getting the care for my family member that he/she wants.
6 units on a scale6 units on a scale6 units on a scale
Perceived Competence, FAMILY
I feel able to meet the challenge of getting the care for my family member that he/she wants.
6 units on a scale6 units on a scale6 units on a scale
Perceived Competence, FAMILY
I feel confident in my ability to get the care for my family member that he/she wants.
6 units on a scale6 units on a scale6 units on a scale
Quality of Family Experience - Preparation Issues13.4 scores on a scale
STANDARD_DEVIATION 3.2
13.3 scores on a scale
STANDARD_DEVIATION 3.3
13.5 scores on a scale
STANDARD_DEVIATION 3
Quality of Family Experience - Relationship with Healthcare Providers4.03 scores on a scale
STANDARD_DEVIATION 0.85
4.02 scores on a scale
STANDARD_DEVIATION 0.89
4.03 scores on a scale
STANDARD_DEVIATION 0.81
Quality of Family Experience - Sense of Completion3.35 scores on a scale
STANDARD_DEVIATION 1.27
3.32 scores on a scale
STANDARD_DEVIATION 1.27
3.38 scores on a scale
STANDARD_DEVIATION 1.28
Race (NIH/OMB)
American Indian or Alaska Native
5 Participants27 Participants0 Participants7 Participants9 Participants6 Participants
Race (NIH/OMB)
Asian
8 Participants26 Participants2 Participants7 Participants5 Participants4 Participants
Race (NIH/OMB)
Black or African American
8 Participants45 Participants0 Participants16 Participants7 Participants14 Participants
Race (NIH/OMB)
More than one race
5 Participants57 Participants2 Participants24 Participants22 Participants4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
3 Participants11 Participants0 Participants2 Participants4 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
9 Participants31 Participants0 Participants3 Participants4 Participants15 Participants
Race (NIH/OMB)
White
186 Participants780 Participants19 Participants205 Participants190 Participants180 Participants
Region of Enrollment
United States
224 participants977 participants23 participants264 participants241 participants225 participants
Relationship, Family
Child
133 Participants71 Participants62 Participants
Relationship, Family
Friend
8 Participants3 Participants5 Participants
Relationship, Family
Other relationship
6 Participants4 Participants2 Participants
Relationship, Family
Other relative
18 Participants8 Participants10 Participants
Relationship, Family
Parent
108 Participants58 Participants50 Participants
Relationship, Family
Sibling
64 Participants32 Participants32 Participants
Relationship, Family
Spouse/Partner
168 Participants88 Participants80 Participants
Sex/Gender, Customized
Female
78 Participants556 Participants18 Participants183 Participants175 Participants102 Participants
Sex/Gender, Customized
Male
146 Participants420 Participants5 Participants81 Participants65 Participants123 Participants
Sex/Gender, Customized
Unknown or Not Reported
0 Participants1 Participants0 Participants0 Participants1 Participants0 Participants
Type of Insurance, Patients
Medicare
138 Participants288 Participants150 Participants
Type of Insurance, Patients
Military
8 Participants15 Participants7 Participants
Type of Insurance, Patients
Other
6 Participants12 Participants6 Participants
Type of Insurance, Patients
Private/commercial
71 Participants132 Participants61 Participants
Type of Insurance, Patients
Unknown
1 Participants2 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
111 / 22494 / 2250 / 2410 / 2640 / 23
other
Total, other adverse events
0 / 2240 / 2250 / 2410 / 2640 / 23
serious
Total, serious adverse events
0 / 2240 / 2250 / 2410 / 2640 / 23

Outcome results

Primary

Depression Symptoms, Family (HADS-D)

Family member symptoms of depression and anxiety assessed with the Hospital Anxiety and Depression Scale (HADS). The HADS is a reliable and valid 14-item, 2-domain (anxiety and depression) tool used to assess symptoms of psychological distress. Seven items evaluate anxiety and seven evaluate depression. Each item is scored on a 4-point scale (ranging from 0-3. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the sum of 7 items measuring depression, weighted for the number of items with valid responses. The sum could range from 0 to 21, with higher values indicating greater depression (i.e., worse outcome),

Time frame: 1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline value

Population: Family members with answers to at least half (4 of 7) of the HADS depression items at baseline and also with answers to at least half of the HADS depression items at one or more of the three follow-up points.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyDepression Symptoms, Family (HADS-D)at 1-month6.4 score on a scaleStandard Deviation 4.4
Usual Care/CONTROL: FamilyDepression Symptoms, Family (HADS-D)at 3-months6.3 score on a scaleStandard Deviation 4.3
Usual Care/CONTROL: FamilyDepression Symptoms, Family (HADS-D)at 6-months5.9 score on a scaleStandard Deviation 4.1
Facilitator-Based INTERVENTION: FamilyDepression Symptoms, Family (HADS-D)at 1-month6.5 score on a scaleStandard Deviation 4.3
Facilitator-Based INTERVENTION: FamilyDepression Symptoms, Family (HADS-D)at 3-months5.9 score on a scaleStandard Deviation 4.1
Facilitator-Based INTERVENTION: FamilyDepression Symptoms, Family (HADS-D)at 6-months5.9 score on a scaleStandard Deviation 4.5
Comparison: Superior outcome for Group2 (Facilitator-based INTERVENTION: Family)p-value: 0.68895% CI: [-0.505, 0.764]Mixed Models Analysis
p-value: 0.51Mixed Models Analysis
Secondary

Anxiety Symptoms, Family (HADS-A)

Family member symptoms of depression and anxiety assessed with the Hospital Anxiety and Depression Scale (HADS). The HADS is a reliable and valid 14-item, 2-domain (anxiety and depression) tool used to assess symptoms of psychological distress. Seven items evaluate anxiety and seven evaluate depression. Each item is scored on a 4-point scale (ranging from 0-3. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the sum of 7 items measuring anxiety, weighted for the number of items with valid responses. The sum could range from 0 to 21, with higher values indicating greater anxiety (i.e., worse outcome)

Time frame: 1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline value

Population: Family members with answers to at least half (4 of 7) of the HADS anxiety items at baseline and also with answers to at least half of the HADS anxiety items at one or more of the three follow-up points.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyAnxiety Symptoms, Family (HADS-A)at 1-month8.2 score on a scaleStandard Deviation 4.5
Usual Care/CONTROL: FamilyAnxiety Symptoms, Family (HADS-A)at 3-months8.4 score on a scaleStandard Deviation 4.8
Usual Care/CONTROL: FamilyAnxiety Symptoms, Family (HADS-A)at 6-months8.1 score on a scaleStandard Deviation 4.8
Facilitator-Based INTERVENTION: FamilyAnxiety Symptoms, Family (HADS-A)at 1-month8.4 score on a scaleStandard Deviation 4.3
Facilitator-Based INTERVENTION: FamilyAnxiety Symptoms, Family (HADS-A)at 3-months8.2 score on a scaleStandard Deviation 4.4
Facilitator-Based INTERVENTION: FamilyAnxiety Symptoms, Family (HADS-A)at 6-months7.9 score on a scaleStandard Deviation 4.6
Comparison: Superior outcome for Group2 (Facilitator-based INTERVENTION: Family)p-value: 0.65895% CI: [-0.491, 0.777]Mixed Models Analysis
p-value: 0.268Mixed Models Analysis
Secondary

Goal-Concordant Care, Family Assessment

Concordance between the care patients want and the care they receive is measured with two questions from the SUPPORT study. The first defines preference (care focused on extending life even with more pain and discomfort vs. care focused on relieving pain and discomfort even with not living as long.) The second assesses perception of current treatment using the same options. The outcome is a dichotomous variable of whether preference matches care received. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was coded 1 if the respondent's perception of the focus of care the patient received (comfort vs. life extension) matched their perception of the patient's preferred focus of care; and 0 if the perceived focus of care received did not match the perceived patient's care preference. If the response to either item was don't know, the outcome was coded 0. The higher value indicated goal-concordant care (the better outcome).

Time frame: 1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline value

Population: Family members who - at baseline - provided valid responses to both component items or who said don't know to either item; and who also at one or more of the follow-up points - provided valid responses to both component items or who said don't know to either item.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyGoal-Concordant Care, Family Assessmentat 1-month0.57 score on a scaleStandard Deviation 0.497
Usual Care/CONTROL: FamilyGoal-Concordant Care, Family Assessmentat 3-months0.57 score on a scaleStandard Deviation 0.497
Usual Care/CONTROL: FamilyGoal-Concordant Care, Family Assessmentat 6-months0.59 score on a scaleStandard Deviation 0.495
Facilitator-Based INTERVENTION: FamilyGoal-Concordant Care, Family Assessmentat 1-month0.63 score on a scaleStandard Deviation 0.484
Facilitator-Based INTERVENTION: FamilyGoal-Concordant Care, Family Assessmentat 3-months0.65 score on a scaleStandard Deviation 0.479
Facilitator-Based INTERVENTION: FamilyGoal-Concordant Care, Family Assessmentat 6-months0.64 score on a scaleStandard Deviation 0.481
Comparison: Superior outcome for Group 2 (Facilitator-based INTERVENTION: Family)p-value: 0.05395% CI: [-0.791, 0.005]Mixed Models Analysis
p-value: 0.039Mixed Models Analysis
Secondary

Healthcare Costs, 30 Days - Patient

Total hospitalization costs for the 30-day period beginning with the date of randomization, adjusted to their value in December 2023 based on the Consumer Price Index for Medical Care. Values ranged from $1,631.73 to $585,386.34, with higher values indicating worse outcomes; missing if the patient was randomized after index hospitalization discharge.

Time frame: Randomization to 30 days after randomization

Population: Patients who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)
Usual Care/CONTROL: FamilyHealthcare Costs, 30 Days - Patient103,731.28 USDollar (inflation-adjusted total cost)
Facilitator-Based INTERVENTION: FamilyHealthcare Costs, 30 Days - Patient99,087.38 USDollar (inflation-adjusted total cost)
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.59995% CI: [-0.000003, 0.0000053]other type of regression
Secondary

Healthcare Costs, Discharge - Patient

Total hospitalization costs from date of randomization to index hospitalization discharge. Costs ranged from $1,631.73 to $1,299,781.53, with higher value indicating a worse outcome; missing if the patient was randomized after discharge from the index hospitalization.

Time frame: Randomization to discharge from index hospitalization, up to 183 days

Population: Patients who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)
Usual Care/CONTROL: FamilyHealthcare Costs, Discharge - Patient124,358.13 USDollar (inflation-adjusted total cost)
Facilitator-Based INTERVENTION: FamilyHealthcare Costs, Discharge - Patient129,058.54 USDollar (inflation-adjusted total cost)
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.7195% CI: [-0.0000057, 0.0000039]other type of regression
Secondary

Healthcare Utilization: Hospital Free Days, 183 Days - Patient

Number of full days on which the patient was alive and not in the hospital between the randomization date and 182 days after the randomization date. Values could range from 0 to 183, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.

Time frame: 183 days after randomization

Population: Patients who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyHealthcare Utilization: Hospital Free Days, 183 Days - Patient93.66 daysStandard Deviation 74.03
Facilitator-Based INTERVENTION: FamilyHealthcare Utilization: Hospital Free Days, 183 Days - Patient98.13 daysStandard Deviation 72.55
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.53395% CI: [-9.367, 18.097]Regression, Linear
Secondary

Healthcare Utilization: Hospital Free Days, 30 Days - Patient

Number of full days on which the patient was alive and not in the hospital between the randomization date and 29 days after the randomization date. Values could range from 0 to 30, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.

Time frame: 30 days after randomization

Population: Patients who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyHealthcare Utilization: Hospital Free Days, 30 Days - Patient5.65 daysStandard Deviation 8.45
Facilitator-Based INTERVENTION: FamilyHealthcare Utilization: Hospital Free Days, 30 Days - Patient6.78 daysStandard Deviation 8.74
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.18395% CI: [-0.511, 2.666]Regression, Linear
Secondary

Healthcare Utilization: Hospital Free Days, 91 Days - Patient

Number of full days on which the patient was alive and not in the hospital between the randomization date and 90 days after the randomization date. Values could range from 0 to 91, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.

Time frame: 91 days after randomization

Population: Patients who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyHealthcare Utilization: Hospital Free Days, 91 Days - Patient39.63 daysStandard Deviation 32.95
Facilitator-Based INTERVENTION: FamilyHealthcare Utilization: Hospital Free Days, 91 Days - Patient41.43 daysStandard Deviation 33.29
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.59395% CI: [-4.518, 7.892]Regression, Linear
Secondary

Healthcare Utilization: Hospital Readmission - Patient

Documentation in the patient's electronic health record of hospital readmission within 30 days after discharge from the index hospitalization: 0=no readmission, 1=one or more readmissions; missing if index hospitalization still ongoing at the end of the 183-day follow-up period, patient death during index hospitalization, or randomization occurred after index hospitalization discharge. Valid outcomes could be either 0 or 1, with higher value indicating a worse outcome.

Time frame: within 30 days after discharge from the index hospitalization

Population: Patients whose index hospitalization had ended before the end of the 183-day follow-up period, who did not die during the index hospitalization, and who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyHealthcare Utilization: Hospital Readmission - Patient0.10 score on a scale (0,1)Standard Deviation 0.31
Facilitator-Based INTERVENTION: FamilyHealthcare Utilization: Hospital Readmission - Patient0.19 score on a scale (0,1)Standard Deviation 0.39
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.02995% CI: [0.009, 0.169]Regression, Linear
Secondary

Healthcare Utilization: ICU Free Days, 183 Days - Patient

Number of full days on which the patient was alive and not in an ICU between the randomization date and 182 days after the randomization date. Values could range from 0 to 183, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.

Time frame: 183 days after randomization

Population: Patients who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyHealthcare Utilization: ICU Free Days, 183 Days - Patient113.96 daysStandard Deviation 80.66
Facilitator-Based INTERVENTION: FamilyHealthcare Utilization: ICU Free Days, 183 Days - Patient122.15 daysStandard Deviation 76.32
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.27395% CI: [-6.479, 22.868]Regression, Linear
Secondary

Healthcare Utilization: ICU Free Days, 30 Days - Patient

Number of full days on which the patient was alive and not in an ICU between the randomization date and 29 days after the randomization date. Values could range from 0 to 30, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.

Time frame: 30 days after randomization

Population: Patients who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyHealthcare Utilization: ICU Free Days, 30 Days - Patient18.54 daysStandard Deviation 11.9
Facilitator-Based INTERVENTION: FamilyHealthcare Utilization: ICU Free Days, 30 Days - Patient19.62 daysStandard Deviation 10.59
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.31895% CI: [-1.032, 3.173]Regression, Linear
Secondary

Healthcare Utilization: ICU Free Days, 91 Days - Patient

Number of full days on which the patient was alive and not in an ICU between the randomization date and 90 days after the randomization date. Values could range from 0 to 91, with higher value indicating a better outcome; missing if randomization occurred after index hospitalization discharge.

Time frame: 91 days after randomization

Population: Patients who were randomized before index hospitalization discharge.

ArmMeasureValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyHealthcare Utilization: ICU Free Days, 91 Days - Patient58.20 daysStandard Deviation 38.2
Facilitator-Based INTERVENTION: FamilyHealthcare Utilization: ICU Free Days, 91 Days - Patient62.32 daysStandard Deviation 35.32
Comparison: Superior outcome for Group2 (Patient-Intervention)p-value: 0.24195% CI: [-2.773, 11.007]Regression, Linear
Secondary

Impact of Event, Family Assessment (IES-6)

The Impact of Event Scale-6 (IES-6), derived from the IES-R, uses six self-report items to assess subjective distress caused by a traumatic event. Items are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely). For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the sum of 6 items measuring the traumatic impact of events, weighted for the number of items with valid responses. The sum could range from 0 to 24, with higher values indicating greater traumatic impact (i.e., worse outcome)

Time frame: 1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome

Population: Family members with answers to at least half (3 of 6) of the IES items at one or more of the three follow-up points.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyImpact of Event, Family Assessment (IES-6)at 1-month11 score on a scaleStandard Deviation 6
Usual Care/CONTROL: FamilyImpact of Event, Family Assessment (IES-6)at 3-months9 score on a scaleStandard Deviation 6
Usual Care/CONTROL: FamilyImpact of Event, Family Assessment (IES-6)at 6-months9 score on a scaleStandard Deviation 6
Facilitator-Based INTERVENTION: FamilyImpact of Event, Family Assessment (IES-6)at 1-month9.4 score on a scaleStandard Deviation 5.9
Facilitator-Based INTERVENTION: FamilyImpact of Event, Family Assessment (IES-6)at 3-months8.9 score on a scaleStandard Deviation 6.4
Facilitator-Based INTERVENTION: FamilyImpact of Event, Family Assessment (IES-6)at 6-months8.1 score on a scaleStandard Deviation 6
Comparison: Superior outcome for Group2 (Facilitator-based INTERVENTION: Family)p-value: 0.23995% CI: [-0.425, 1.7]Mixed Models Analysis
p-value: 0.17Mixed Models Analysis
Secondary

Quality of Family Experience - Preparation Issues (QUAL-E Fam)

Measure of family experience of patients with serious illness. The QUAL-E (Fam) is a validated 17-item companion instrument to the patient QUAL-E measure of quality of life at the end of life, with four subscales and two general items. This study is using 11 items from three subscales: Relationship with Health Care Provider, Completion, and Preparation subscales. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the sum of valid responses to QUAL-E (Fam) items #12, 13, 14, and 15, weighted for the number of items with valid responses. The sum could range from 4 to 20, with higher values indicating greater preparation (i.e., better outcome).

Time frame: 1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline value

Population: Family members with answers to at least half (2 of 4) of QUAL-E (Fam) items #12, 13, 14, and 15 at baseline and also with answers to at least half of those items at one or more of the three follow-up points; higher score indicates higher preparation.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyQuality of Family Experience - Preparation Issues (QUAL-E Fam)at 1-month13.5 score on a scale, sum of itemsStandard Deviation 3.2
Usual Care/CONTROL: FamilyQuality of Family Experience - Preparation Issues (QUAL-E Fam)at 3-months13.3 score on a scale, sum of itemsStandard Deviation 3.2
Usual Care/CONTROL: FamilyQuality of Family Experience - Preparation Issues (QUAL-E Fam)at 6-months13.6 score on a scale, sum of itemsStandard Deviation 3.4
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Preparation Issues (QUAL-E Fam)at 1-month13.9 score on a scale, sum of itemsStandard Deviation 3.2
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Preparation Issues (QUAL-E Fam)at 3-months14.0 score on a scale, sum of itemsStandard Deviation 3.2
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Preparation Issues (QUAL-E Fam)at 6-months14.0 score on a scale, sum of itemsStandard Deviation 3.2
Comparison: Superior outcome for Group 2 (Facilitator-based INTERVENTION: Family)p-value: 0.0695% CI: [-0.919, 0.02]Mixed Models Analysis
p-value: 0.701Mixed Models Analysis
Secondary

Quality of Family Experience - Relationship With Healthcare Providers (QUAL-E Fam)

Measure of family experience of patients with serious illness. The QUAL-E (Fam) is a validated 17-item companion instrument to the patient QUAL-E measure of quality of life at the end of life, with four subscales and two general items. This study is using 11 items from three subscales: Relationship with Health Care Provider, Completion, and Preparation subscales. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the mean of the valid responses to QUAL-E (Fam) items #5, 6, 7, and 8. The mean could range from 1 to 5, with higher values indicating higher quality of relationship (i.e., better outcome).

Time frame: 1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline value

Population: Family members with answers to at least half (2 of 4) of QUAL-E (Fam) items #5, 6, 7, and 8 at baseline and also with answers to at least half of those items at one or more of the three follow-up points; higher score indicates higher quality of relationship.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyQuality of Family Experience - Relationship With Healthcare Providers (QUAL-E Fam)at 1-month3.94 score on a scale, mean value of 4 itemsStandard Deviation 0.85
Usual Care/CONTROL: FamilyQuality of Family Experience - Relationship With Healthcare Providers (QUAL-E Fam)at 3-months3.51 score on a scale, mean value of 4 itemsStandard Deviation 1.16
Usual Care/CONTROL: FamilyQuality of Family Experience - Relationship With Healthcare Providers (QUAL-E Fam)at 6-months3.54 score on a scale, mean value of 4 itemsStandard Deviation 1.13
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Relationship With Healthcare Providers (QUAL-E Fam)at 1-month4.10 score on a scale, mean value of 4 itemsStandard Deviation 0.77
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Relationship With Healthcare Providers (QUAL-E Fam)at 3-months3.87 score on a scale, mean value of 4 itemsStandard Deviation 0.97
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Relationship With Healthcare Providers (QUAL-E Fam)at 6-months3.64 score on a scale, mean value of 4 itemsStandard Deviation 1.11
Comparison: Superior outcome for Group 2 (Facilitator-based INTERVENTION: Family)p-value: 0.0195% CI: [-0.353, -0.048]Mixed Models Analysis
p-value: 0.175Mixed Models Analysis
Secondary

Quality of Family Experience - Sense of Completion (QUAL-E Fam)

Measure of family experience of patients with serious illness. The QUAL-E (Fam) is a validated 17-item companion instrument to the patient QUAL-E measure of quality of life at the end of life, with four subscales and two general items. This study is using 11 items from three subscales: Relationship with Health Care Provider, Completion, and Preparation subscales. For each of three follow-up points (1-month, 3-month, and 6-month), the response variable was the mean of the valid responses to QUAL-E (Fam) items #9, 10, and 11. The mean could range from 1 to 5, with higher values indicating higher sense of completion (i.e., better outcome).

Time frame: 1-month, 3-month, and 6-month values for the outcome, using a linear mixed-effects model that evaluates the effects of the intervention, time point, and the intervention-time interaction on the outcome after adjustment for the baseline value

Population: Family members with answers to at least half (2 of 3) of QUAL-E (Fam) items #9, 10, and 11 at baseline and also with answers to at least half of those items at one or more of the three follow-up points; higher score indicates higher sense of completion.

ArmMeasureGroupValue (MEAN)Dispersion
Usual Care/CONTROL: FamilyQuality of Family Experience - Sense of Completion (QUAL-E Fam)at 1-month3.68 score on a scale, mean value of 3 itemsStandard Deviation 1.16
Usual Care/CONTROL: FamilyQuality of Family Experience - Sense of Completion (QUAL-E Fam)at 3-months3.98 score on a scale, mean value of 3 itemsStandard Deviation 0.98
Usual Care/CONTROL: FamilyQuality of Family Experience - Sense of Completion (QUAL-E Fam)at 6-months4.05 score on a scale, mean value of 3 itemsStandard Deviation 0.93
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Sense of Completion (QUAL-E Fam)at 1-month3.75 score on a scale, mean value of 3 itemsStandard Deviation 1.02
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Sense of Completion (QUAL-E Fam)at 3-months3.94 score on a scale, mean value of 3 itemsStandard Deviation 1.03
Facilitator-Based INTERVENTION: FamilyQuality of Family Experience - Sense of Completion (QUAL-E Fam)at 6-months4.01 score on a scale, mean value of 3 itemsStandard Deviation 1
Comparison: Superior outcome for Group 2 (Facilitator-based INTERVENTION: Family)p-value: 0.81795% CI: [-0.203, 0.16]Mixed Models Analysis
p-value: 0.949Mixed Models Analysis
Other Pre-specified

Key Implementation Factors

Qualitative interviews after individual participation. Interviews will be guided by the Consolidated Framework for Implementation Research (CFIR) to explore the factors associated with implementation, including aspects of the intervention, inner and outer settings, individuals, and processes of care. Individual constructs within these domains were chosen to fit this specific intervention and context.

Time frame: 6-months after randomization

Other Pre-specified

Key Implementation Outcomes

Qualitative interviews after individual participation. Interviews will also explore three key implementation outcomes (acceptability, fidelity, penetration) that will guide future dissemination of the intervention.

Time frame: 6-months after randomization

Other Pre-specified

Measure of Acceptability of Intervention - Family in the Intervention Group

The Acceptability of Intervention Measure (AIM) is a 4 item measure with proven reliability, validity and responsiveness to change. It is designed to assess participants' perception of the intervention in which they participated as agreeable (meets my approval), palatable (appealing to me) or satisfactory (like it, welcome it). Response options include completely disagree, disagree, neither agree nor disagree, agree and completely agree. These items were asked of the intervention participants at the conclusion of the 3-month intervention phase.

Time frame: Assessed on 3-month questionnaires

Population: These questionnaire items were only asked of the family subjects in the intervention arm. Reporting valid responses on the 3-month questionnaire distributed at the end of the intervention period.

ArmMeasureGroupValue (MEDIAN)
Facilitator-Based INTERVENTION: FamilyMeasure of Acceptability of Intervention - Family in the Intervention GroupThe facilitator intervention meets my approval.5 score on a scale
Facilitator-Based INTERVENTION: FamilyMeasure of Acceptability of Intervention - Family in the Intervention GroupThe facilitator intervention is appealing to me.5 score on a scale
Facilitator-Based INTERVENTION: FamilyMeasure of Acceptability of Intervention - Family in the Intervention GroupI like the facilitator intervention.5 score on a scale
Facilitator-Based INTERVENTION: FamilyMeasure of Acceptability of Intervention - Family in the Intervention GroupI welcome the facilitator intervention.5 score on a scale
Other Pre-specified

Perceived Competence Scale (PCS), 1 Month - Family

The Perceived Competence Scale (PCS) is a 4-item questionnaire assessing participants' feelings of competence. Items can be worded differently for different target behaviors. Responses range from Not at all true (1) to Very True (7); higher score on the latent variable would indicate greater competence. We will evaluate this mediator cross-sectionally.

Time frame: Assessed on 1-month questionnaires

Population: Perceived Competence Scale, 4 items collected by self-report via survey item at each assessment point. These data were only collected from family member subjects. Unit of Measure is self-assessed competence (1 \[not at all true\] through 3 \[somewhat true\] to 7 \[very true\]). PCS was not asked in after-death questionnaires. Number analyzed only reflects valid responses (not skipped or missing).

ArmMeasureGroupValue (MEDIAN)
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 1 Month - FamilyI feel confident in my ability to get the care for my family member that he/she wants.5 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 1 Month - FamilyI am capable of getting the care for my family member that he/she wants.5 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 1 Month - FamilyI am able to get the care for my family member that he/she wants.5 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 1 Month - FamilyI feel able to meet the challenge of getting the care for my family member that he/she wants.5 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 1 Month - FamilyI feel able to meet the challenge of getting the care for my family member that he/she wants.5 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 1 Month - FamilyI feel confident in my ability to get the care for my family member that he/she wants.6 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 1 Month - FamilyI am able to get the care for my family member that he/she wants.5 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 1 Month - FamilyI am capable of getting the care for my family member that he/she wants.6 score on a scale
Other Pre-specified

Perceived Competence Scale (PCS), 3 Months - Family

The Perceived Competence Scale (PCS) is a 4-item questionnaire assessing participants' feelings of competence. Items can be worded differently for different target behaviors. Responses range from Not at all true (1) to Very True (7); higher score on the latent variable would indicate greater competence. We will evaluate this mediator cross-sectionally.

Time frame: Assessed on 3-month questionnaires

Population: Perceived Competence Scale, 4 items collected by self-report via survey item at each assessment point. These data were only collected from family member subjects. Unit of Measure is self-assessed competence (1 \[not at all true\] through 3 \[somewhat true\] to 7 \[very true\]). PCS was not asked in after-death questionnaires. Number analyzed only reflects valid responses (not skipped or missing).

ArmMeasureGroupValue (MEDIAN)
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 3 Months - FamilyI feel confident in my ability to get the care for my family member that he/she wants.5 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 3 Months - FamilyI am capable of getting the care for my family member that he/she wants.5 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 3 Months - FamilyI feel able to meet the challenge of getting the care for my family member that he/she wants.5 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 3 Months - FamilyI am able to get the care for my family member that he/she wants.5 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 3 Months - FamilyI am able to get the care for my family member that he/she wants.6 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 3 Months - FamilyI feel confident in my ability to get the care for my family member that he/she wants.6 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 3 Months - FamilyI feel able to meet the challenge of getting the care for my family member that he/she wants.6 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 3 Months - FamilyI am capable of getting the care for my family member that he/she wants.6 score on a scale
Other Pre-specified

Perceived Competence Scale (PCS), 6 Months - Family

The Perceived Competence Scale (PCS) is a 4-item questionnaire assessing participants' feelings of competence. Items can be worded differently for different target behaviors. Responses range from Not at all true (1) to Very True (7); higher score on the latent variable would indicate greater competence. We will evaluate this mediator cross-sectionally.

Time frame: Assessed on 6-month questionnaires

Population: Perceived Competence Scale, 4 items collected by self-report via survey item at each assessment point. These data were only collected from family member subjects. Unit of Measure is self-assessed competence (1 \[not at all true\] through 3 \[somewhat true\] to 7 \[very true\]). PCS was not asked in after-death questionnaires. Number analyzed only reflects valid responses (not skipped or missing).

ArmMeasureGroupValue (MEDIAN)
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 6 Months - FamilyI feel confident in my ability to get the care for my family member that he/she wants.6 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 6 Months - FamilyI am capable of getting the care for my family member that he/she wants.6 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 6 Months - FamilyI am able to get the care for my family member that he/she wants.5 score on a scale
Usual Care/CONTROL: FamilyPerceived Competence Scale (PCS), 6 Months - FamilyI feel able to meet the challenge of getting the care for my family member that he/she wants.5 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 6 Months - FamilyI feel able to meet the challenge of getting the care for my family member that he/she wants.5 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 6 Months - FamilyI feel confident in my ability to get the care for my family member that he/she wants.6 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 6 Months - FamilyI am able to get the care for my family member that he/she wants.5 score on a scale
Facilitator-Based INTERVENTION: FamilyPerceived Competence Scale (PCS), 6 Months - FamilyI am capable of getting the care for my family member that he/she wants.6 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026